Cytokinetics, Incorporated · NASDAQ:CYTK
FMR LLC reported a 10.90% stake in Cytokinetics, Incorporated (Schedule 13G/A)
Event Jul 31, 2025 · Filed Aug 7, 2025
FMR LLC reported a 10.90% stake in Cytokinetics, Incorporated, 13,101,596 shares, as a passive investor on Jul 31, 2025. Filed Aug 7, 2025 (Schedule 13G/A).
- Stake
- 10.90%
- Shares
- 13,101,596
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| FMR LLC | 10.90% | 13,101,596 |
| Abigail P. Johnson | 10.90% | 13,101,596 |
Source
Related
- Cytokinetics, Incorporated
- FMR LLC
- Cytokinetics, Incorporated shareholders
- Schedule 13G/A · FMR LLC · Jul 8, 2026
- Schedule 13G/A · FMR LLC · May 6, 2026
- Schedule 13G/A · FMR LLC · Feb 12, 2025
- Form 4 · Malik Fady Ibraham · Oct 20, 2026
- Form 4 · Daly James M · Oct 20, 2026
- Form 4 · Henderson John T · Oct 20, 2026
- Form 4 · Wysenski Nancy · Oct 20, 2026
- Form 4 · Harrington Robert Arthur · Oct 20, 2026